metastatic prostate cancer

Showing 1 - 25 of 111

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Metastatic Prostate Cancer Trial in Salt Lake City (dietary supplement, other, behavioral)

Not yet recruiting
  • Metastatic Prostate Cancer
  • creatine monohydrate
  • +2 more
  • Salt Lake City, Utah
    Huntsman Cancer Institute
Oct 30, 2023

Advanced Prostate Cancer, Metastatic Prostate Cancer, Metastatic Prostate Neuroendocrine Carcinoma Trial in Boston

Not yet recruiting
  • Advanced Prostate Cancer
  • +2 more
  • Boston, Massachusetts
  • +1 more
Sep 25, 2023

Metastatic Prostate Cancer Trial in Nanjing (177Lu-PSMA-0057)

Recruiting
  • Metastatic Prostate Cancer
  • Nanjing, Jiangsu, China
    Nanjing First Hospital
Sep 17, 2023

PROSTATE CANCER, Metastatic Prostate Cancer, Metastatic Prostate Carcinoma Trial in Boston (Supervised Circuit Training)

Not yet recruiting
  • PROSTATE CANCER
  • +2 more
  • Supervised Circuit Training
  • Boston, Massachusetts
  • +2 more
Sep 13, 2023

A Journey Into Participation Patterns Among Metastatic Prostate

Not yet recruiting
  • Metastatic Prostate Cancer
    • San Francisco, California
      Power Life Sciences
    Aug 18, 2023

    Metastatic Prostate Cancer, Hormone Sensitive Prostate Cancer, Chemo Effect Trial in Nanjing (Docetaxel, Rezvilutamide)

    Recruiting
    • Metastatic Prostate Cancer
    • +2 more
    • Nanjing, Jiangsu, China
      Urology dpt, First Affiliated Hospital of Nanjing Medical Univer
    Aug 2, 2023

    Metastasis, Metastatic Breast Cancer, Metastatic Prostate Cancer Trial in Spain (To propose a diagnostic test to determine the

    Recruiting
    • Metastasis
    • +4 more
    • To propose a diagnostic test to determine the viability of Stereotactic ABlative Radiotherapy (SABR).
    • +2 more
    • Reus, Tarragona, Spain
    • +20 more
    Jul 3, 2023

    Cancer, Prostate Cancer, Metastatic Cancer Trial (177Lu-PSMA-I&T - escalating renal absorbed dose, 177Lu-PSMA-I&T - recommended

    Not yet recruiting
    • Cancer
    • +3 more
    • 177Lu-PSMA-I&T - escalating renal absorbed dose
    • 177Lu-PSMA-I&T - recommended phase 2 regime
    • (no location specified)
    Jun 14, 2023

    Liquid Biopsy Genomic Profiling on Treatment Metastatic Prostate

    Recruiting
    • Metastatic Prostate Cancer
    • Liquid Biopsy
    • Archival Tumor DNA sequencing
    • Barcelona, Spain
      SOLTI Cancer Research Group
    May 22, 2023

    Advanced Prostate Cancer, Metastatic Prostate Cancer Trial (RO7656594)

    Not yet recruiting
    • Advanced Prostate Cancer
    • Metastatic Prostate Cancer
    • (no location specified)
    Mar 24, 2023

    Prostate Cancer, Breast Cancer, Kidney Cancer Trial in Tampere (behavioral, drug, other)

    Not yet recruiting
    • Prostate Cancer
    • +11 more
    • Guided physical exercise
    • +2 more
    • Tampere, Länsi-Suomi, Finland
      Tampere University Hospital
    Apr 3, 2023

    Metastatic Prostate Cancer Trial (Darolutamide, Radium-223)

    Not yet recruiting
    • Metastatic Prostate Cancer
    • (no location specified)
    Mar 6, 2023

    Prostate Cancer, Metastatic Prostate Cancer Trial in Tampa (Abiraterone, Enzalutamide, Apalutamide)

    Recruiting
    • Prostate Cancer
    • Metastatic Prostate Cancer
    • Tampa, Florida
      Moffitt Cancer Center
    Feb 21, 2023

    Metastatic Prostate Cancer, Castration-Sensitive Prostate Cancer Trial in Shanghai (drug, procedure, radiation)

    Not yet recruiting
    • Metastatic Prostate Cancer
    • Castration-Sensitive Prostate Cancer
    • Shanghai, Shanghai, China
    • +1 more
    Feb 4, 2023

    Metastatic Breast Cancer, Metastatic Prostate Cancer, Bone Metastases Trial in Austria, Germany, Switzerland (Denosumab (reduced

    Recruiting
    • Metastatic Breast Cancer
    • +2 more
    • Denosumab (reduced dosing)
    • Denosumab (standard dosing)
    • Feldkirch, Austria
    • +49 more
    Jan 30, 2023

    Breast Cancer, Ovarian Cancer, Pancreatic Cancer Trial in United States (Standard Genetic Counseling, Educational Video)

    Active, not recruiting
    • Breast Cancer
    • +3 more
    • Standard Genetic Counseling
    • Educational Video
    • Boston, Massachusetts
    • +5 more
    Jan 25, 2023

    Metastatic Prostate Cancer, Prostate Cancer, Prostate Tumor Trial run by the NCI (M7824, N-803, MVA-BN-Brachyury)

    Recruiting
    • Metastatic Prostate Cancer
    • +4 more
    • M7824
    • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 20, 2023

    Metastatic Prostate Cancer Trial in Spain (Enzalutamide, Talazoparib)

    Recruiting
    • Metastatic Prostate Cancer
    • Badalona, Spain
    • +8 more
    Jan 18, 2023

    Advanced Prostate Cancer, Metastatic Prostate Cancer, Locally Advanced Prostate Cancer Trial in China (Triptorelin pamoate

    Recruiting
    • Advanced Prostate Cancer
    • +2 more
    • Triptorelin pamoate (embonate) salt
    • Beijing, China
    • +24 more
    Jan 17, 2023

    Determine Frequency of DNA-repair Defects in Metastatic Prostate

    Completed
    • Metastatic Prostate Cancer
    • Saliva, Blood, or and/or Archival Tumor Tissue Collection and Analysis
    • Homewood, Alabama
    • +337 more
    Jan 17, 2023

    Metastatic Prostate Cancer Trial in Australia, United Kingdom (AZD5305, Enzalutamide, Abiraterone Acetate)

    Recruiting
    • Metastatic Prostate Cancer
    • San Diego, California
    • +25 more
    Jan 10, 2023

    Metastatic Prostate Cancer Trial in Worldwide (Ipatasertib, Abiraterone, Placebo)

    Active, not recruiting
    • Metastatic Prostate Cancer
    • Chandler, Arizona
    • +183 more
    Nov 24, 2022

    Metastatic Prostate Cancer Trial in Perth (64Cu-DOTA-TLX592)

    Recruiting
    • Metastatic Prostate Cancer
    • Perth, Western Australia, Australia
    • +1 more
    Nov 25, 2022

    Metastatic Prostate Cancer, Non-metastatic Prostate Cancer, Prostate Cancer Trial in Boston (Darolutamide, Abemaciclib, GNRH-A

    Not yet recruiting
    • Metastatic Prostate Cancer
    • +2 more
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    Nov 14, 2022